Ankaferd BloodStopper

logo

Ankaferd BloodStopper (ABS) is a product claimed to have antihemorrhagic properties.[1] It is used in hospitals and ambulances in Turkey to stop bleeding occurring from external bodily injuries and operations.[2][3] It is the first Turkish medical product officially accredited by the Turkish Ministry of Health.[4]

Hüseyin Cahit Fırat, the developer of ABS, is a Turkish entrepreneur. He is not a doctor of medicine, as his background of study lies in economics, with some contributions in the fields of business and journalism.[5] Firat's interest in herbology led him to the discovery of ABS, which consists entirely of plant-based ingredients.[4]

The final product was attested and finished in the hematology faculty of Hacettepe University in Ankara.[6]

Features

ABS consists of 100% herbal ingredients and contains no synthetic additives.[7] It is made from five plants: Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum and Urtica dioica.

References

  1. ↑ Beyazit, Yavuz; Kurt, Mevlut; Kekilli, Murat; Goker, Hakan; Haznedaroglu, Ibrahim Celalettin (2010). "Evaluation of hemostatic effects of Ankaferd as an alternative medicine" (PDF). Alternative Medicine Review. 15 (4): 329–36. PMID 21194248.
  2. ↑ John R. Saltzman (24 July 2015). Upper Gastrointestinal Bleeding Management, An Issue of Gastrointestinal Endoscopy Clinics,. Elsevier Health Sciences. pp. 548–. ISBN 978-0-323-39099-6.
  3. ↑ "Today's Zaman, Turkish daily news". Retrieved 18 September 2014.
  4. 1 2 "Ankaferd BloodStopper Kanama Durdurucu". ankaferd.com. Retrieved 2014-07-23.
  5. ↑ "Huseyin Cahit Firat, University of California, Riverside, Department of Chemical and Environmental Engineering". ResearchGate. Retrieved 25 September 2014.
  6. ↑ "Dünyayı sarsan Türk" (in Turkish). Sağlık Aktüel. 9 June 2008. Retrieved 18 September 2014.
  7. ↑ "Ankaferd Bloodstopper 3ml Einzelpackung - Bloodstopper". delphos.info. Retrieved 2014-07-23.

External links


This article is issued from Wikipedia - version of the 10/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.